PeptidePedia The community reference

Adverse effects of GLP-1 receptor agonists: difference between revisions

Diff·revision 11 → 12·22:37, 14 Oct 2024

Difference between revision 11 and revision 12 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 11 — 21:36, 30 Sep 2024
AppealsArno (talk)
add category for adverse effects
3,137 bytes ±0
Revision 12 — 22:37, 14 Oct 2024
MassSpecMarv (talk)
add the monitoring recommendation as attributed to the labelling
3,137 bytes ±0
No change to the page source.